Clinical and dosimetric considerations for Y90: recommendations from an international multidisciplinary working group.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 31098749.
- Also identified by DOI 10.1007/s00259-019-04340-5.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The TheraSphere Global Dosimetry Steering Committee was formed in 2017 by BTG International to review existing data and address gaps in knowledge related to dosimetry. This committee is comprised of health care providers with diverse areas of expertise and perspectives on radiation dosimetry. The goal of these recommendations is to optimize glass microspheres radiation therapy for hepatocellular carcinoma while accounting for variables including disease presentation, tumour vascularity, liver function, and curative/palliative intent. The recommendations aim to unify glass microsphere users behind standardized dosimetry methodology that is simple, reproducible and supported by clinical data, with the overarching goal of improving clinical outcomes and advancing the knowledge of dosimetry.
Medical subject headings
- Consensus Statements as Topic
- Practice Guidelines as Topic
- Radiometry
- Radiopharmaceuticals
- Radiotherapy
- Yttrium Radioisotopes